Literature DB >> 30800565

Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.

Yukiko Hasegawa1, Tomoko Nakagami1, Junko Oya1, Chisato Isago1, Moritoshi Kurita1, Yuki Tanaka1, Arata Ito1, Reika Tsuzura1, Naoki Hirota1, Junnosuke Miura1, Yasuko Uchigata1.   

Abstract

INTRODUCTION: Serum lipid management is important for patients with diabetes; however, it has not been examined in our specialized diabetes clinic. AIMS: The aim of the study was to assess the percentage of patients who did not achieve management targets (MT) for low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) and triglycerides (TG), and explore factors related to failure to achieve lipid MT in Japanese patients with type 1 (T1D) and type 2 diabetes (T2D).
METHODS: This cross-sectional study included 795 patients (35% men) with T1D and 4018 patients (60% men) with T2D attending our diabetes center. MTs for serum lipids were in accordance with the guidelines of the Japan Atherosclerosis Society. Logistic regression analysis was performed to identify factors related to failure to achieve MTs for serum lipids.
RESULTS: The percentages of men/women who did not achieve MT for LDL-C were 34.1/31.8% in T1D and 40.5/52.7% in T2D. The corresponding values for TG were 35.1/14.0% in T1D and 50.1/47.9% in T2D, and for HDL-C were 2.5/0% in T1D and 8.6/2.9% in T2D. Increase in body mass index (BMI) and glycated hemoglobin (HbA1c) were significantly and independently associated with failure to achieve lipid MT in patients with T1D and T2D for both sexes.
CONCLUSIONS: The percentages of our patients who did not achieve serum lipid MT were relatively high in T1D and T2D, and higher HbA1c and BMI were associated with failure to achieve serum lipid MTs. More attention should be paid to lipid management in patients with diabetes especially who have higher HbA1c and BMI in our facility.

Entities:  

Keywords:  Diabetes mellitus; HDL-cholesterol; LDL-cholesterol; Management target for serum lipid; Triglyceride

Year:  2018        PMID: 30800565      PMCID: PMC6357242          DOI: 10.1007/s13340-018-0365-z

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  32 in total

1.  Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Authors:  Ruth L Coleman; Richard J Stevens; Ravi Retnakaran; Rury R Holman
Journal:  Diabetes Care       Date:  2007-02-08       Impact factor: 19.112

2.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

Authors:  R J Stevens; V Kothari; A I Adler; I M Stratton
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

3.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

4.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.

Authors:  Y Cui; R S Blumenthal; J A Flaws; M K Whiteman; P Langenberg; P S Bachorik; T L Bush
Journal:  Arch Intern Med       Date:  2001-06-11

5.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Authors:  A Keech; R J Simes; P Barter; J Best; R Scott; M R Taskinen; P Forder; A Pillai; T Davis; P Glasziou; P Drury; Y A Kesäniemi; D Sullivan; D Hunt; P Colman; M d'Emden; M Whiting; C Ehnholm; M Laakso
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

6.  The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population.

Authors:  Tomonori Okamura; Takehito Hayakawa; Takashi Kadowaki; Yoshikuni Kita; Akira Okayama; Hirotsugu Ueshima
Journal:  Atherosclerosis       Date:  2006-01       Impact factor: 5.162

7.  Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.

Authors:  Marius Carstensen; Claus Thomsen; Ole Gotzsche; Jens Juul Holst; Jürgen Schrezenmeir; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2005-02-10

8.  What cause of mortality can we predict by cholesterol screening in the Japanese general population?

Authors:  T Okamura; T Kadowaki; T Hayakawa; Y Kita; A Okayama; H Ueshima
Journal:  J Intern Med       Date:  2003-02       Impact factor: 8.989

9.  Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study.

Authors:  Michiaki Kubo; Yutaka Kiyohara; Isao Kato; Yumihiro Tanizaki; Hisatomi Arima; Keiichi Tanaka; Hidetoshi Nakamura; Ken Okubo; Mitsuo Iida
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914

10.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Authors:  P M Kearney; L Blackwell; R Collins; A Keech; J Simes; R Peto; J Armitage; C Baigent
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.